Background: Readmission among Inflammatory Bowel Disease (IBD) inpatients is common, as is opioid use. Opioid use for IBD has been associated with an increased risk of infection and death, but inconsistently with readmissions. Increasingly, cannabis is viewed as a potentially safer alternative to opioids, though with limited study of potential adverse outcomes such as hospital [...]